CRISPR’s next act: the companies editing the epigenome to treat disease

Daily briefing: Editing the epigenome with CRISPR to treat disease

CRISPR takes a bold leap toward silencing Down syndrome's extra chromosome

Mouse study finds 7% of epigenetic marks are inherited outside Mendelian rules

A new federally funded study using mice reveals that approximately 7% of epigenetic marks—chemical modifications to DNA that don't alter the

New CRISPR Technique Selectively Destroys Cancer Cells with Common Mutation

Researchers at UC Berkeley, UCSF, and Gladstone Institutes have developed a novel CRISPR-based technique called "RNA-Triggered Chromatin Shr

CRISPR's Limitations in Mitochondrial DNA Editing and Emerging Alternatives

The article discusses the limitations of CRISPR gene editing technology in accessing mitochondrial DNA (mtDNA) and the resulting challenges

First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025

In 2025, doctors and scientists in the U.S. successfully performed the world's first custom gene-editing therapy inside a living person—a ne